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Protein modifications by phosphorylation or ubiquitylation have been selected throughout evolution as 
efficient regulatory mechanisms of cellular processes. Cell migration is a complex, highly coordinated 
process where these mechanisms must participate in an integrated manner to transmit signaling 
during migration. In this study, we show that the ubiquitin ligase HERC1 regulates the p38 signaling 
pathway, and that this regulation is mediated by the MAPK kinase MKK3. Moreover, we demonstrate 
a crosstalk between RAF and MKK3/p38 pathways where RAF acts upstream of MKK3. Mechanistically, 
HERC1 regulates the protein levels of C-RAF and MKK3. Thus, HERC1 ubiquitylates C-RAF, targeting 
it for proteasomal degradation, and RAF proteins regulate MKK3 mRNA levels. Accordingly, HERC1 
knockdown induces C-RAF stabilization and activation of RAF proteins; in turn, this activation increases 
MKK3, which phosphorylates and activates p38. The importance of these observations is demonstrated 
by HERC1 regulation of cell migration through regulation of p38 signaling via a RAF-dependent 
mechanism. Thus, HERC1 plays an essential role as a regulator of crosstalk between RAF/MKK3/p38 
signaling pathways during cell migration.
Post-translational modifications can modify proteins and regulate their functions. Protein ubiquitylation is a 
post-translational modification that covalently attaches ubiquitin to target proteins, altering protein function 
in an extraordinary variety of ways. This process occurs in three sequential steps: ubiquitin activation by a 
ubiquitin-activating enzyme (E1); transfer of activated ubiquitin from E1 to ubiquitin-conjugating enzyme (E2); 
and conjugation of ubiquitin to a lysine residue of a substrate protein by ubiquitin ligase enzyme (E3). This cata-
lytic process can be repeated over several cycles, resulting in substrates modified on multiple lysine residues with 
different poly-ubiquitin chains. Since E3 ligases control substrate specificity and the ubiquitylation topology, they 
are emerging as key regulators of cellular processes1–3.
Cell migration plays a fundamental role in multiple physiological and pathological processes, including 
wound healing, embryogenesis, tissue morphogenesis, cancer metastasis, and inflammation. Numerous stud-
ies have demonstrated that mitogen-activated protein kinase (MAPK) pathways, including the Jun N-terminal 
kinase (JNK), p38, and extracellular signal-regulated protein kinase (ERK) signaling pathways, regulate cell 
migration via different mechanisms. Thus, the JNK signaling pathway modulates cell migration by phosphoryl-
ating proteins such as paxillin, DCX, Jun, and microtubule-associated proteins. Meanwhile, the p38 signaling 
pathway regulates migration by phosphorylating MAPK-activated protein kinase 2 (MAPKAP-K2 or MK2) and 
the ERK signaling pathway controls cell movement by phosphorylating myosin light chain kinase, calpain, or 
focal-adhesion kinase4,5.
Several ubiquitin E3 ligases also regulate cell migration by ubiquitylating the key proteins that control stress 
fiber formation, cell polarity, lamellipodial protrusions, and focal adhesion dynamics6. For example, E3 ligases 
Smurf1 and the Cul3/BACURD complex ubiquitylates RhoA to regulate stress fiber formation and cell polar-
ity, while E3 ligase ASB2α ubiquitylates filamins to modulate the elasticity of the actin network, thus regulat-
ing cell spreading and cell migration. E3 ligases HACE1, XIAP, and SCF/FBX19 ubiquitylate Rac1, resulting in 
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its degradation and suppressing lamellipodial protrusions. Conversely, sumoylation of Rac1 by the SUMO E3 
ligase PIAS3 activates Rac1 to promote lamellipodial protrusions. Moreover, Smurf1-dependent ubiquitylation 
of TRAF4 also enhances Rac1 activation. Smurf1 and E3 ligase HECTD1 regulate focal adhesion assembly/disas-
sembly through ubiquitylation of talin head and phosphatidylinositol 4-phosphate 5-kinase type I γ, respectively6.
Proteins containing HECT and RCC1-like domains form the HERC protein family, a subgroup of ubiquitin 
E3 ligases in the HECT family that regulate cellular processes such as cell cycle, cell signaling, DNA damage 
response, or antiviral response, and are implicated in cancer, neurological disorders, and other diseases7. Recently, 
it has been shown that the E3 ligase HERC1 regulates cell proliferation through control of the ERK signaling path-
way targeting MAPK kinase kinase (MAPKKK) C-RAF for proteasomal degradation8. RAF (A-RAF, B-RAF, and 
C-RAF) serine/threonine kinases link RAS activation to activation of the MEK/ERK module. Through this mech-
anism, RAF kinases relay signals inducing cell proliferation, differentiation, and survival. C-RAF also plays an 
essential function in cell migration as a regulator of Rho downstream signaling9. Here, we show for the first time 
that the E3 ligase HERC1 regulates cell migration through activation of the MKK3/p38 module. More impor-
tantly, this activation is dependent on RAF proteins and involves an unexpected and unusual crosstalk between 
these MAPK pathways. Our study helps elucidate the complex regulation of cell migration, where ubiquitylation 
and phosphorylation mechanisms participate in an integrated manner to transmit signaling for cell mobilization.
Results
HERC1 regulates p38 signaling. We have previously shown that the ubiquitin E3 ligase HERC1 regu-
lates the RAF/MEK/ERK signaling pathway8. We wondered whether HERC1 might also regulate other MAPK 
pathways. To answer this question, we decided to analyze the p38 MAPK pathway in HERC1-depleted human 
cells. Human osteosarcoma U2OS cells were transfected with small interfering RNA (siRNA), using two different 
HERC1 siRNAs (Q1 and Q4) and a non-targeting (NT) siRNA. With both HERC1 siRNAs, a significant increase 
in p38 phosphorylation (p-p38) was observed in HERC1-depleted cells (Fig. 1A). Under these conditions, p38 
protein levels (p38) were not modified. Protein levels of Clathrin heavy chain (CHC), α-tubulin or β-actin were 
not modified either. Similar results were observed in other tumorigenic cells (H1299, a human non-small cell 
lung carcinoma cell line) and in non-tumorigenic cells (HEK-293T, a human embryonic kidney 293T cell line) 
(Fig. 1B). These results were also confirmed using short hairpin RNA (shRNA): HEK-293T and U2OS cells were 
infected with mock lentivirus or with lentivirus expressing shRNA against HERC1 (shH1) and an increase in 
p38 phosphorylation (p-p38) was observed in HERC1-depleted cells (Fig. 1C). Similar results were also obtained 
in mouse embryonic fibroblasts (MEFs) (Fig. 1D). To show that the increase in p38 phosphorylation correlates 
with an increase in its activation, we analyzed the phosphorylation of HSP27, a known downstream target of 
p38 activity10, and observed a marked increase in HSP27 phosphorylation in HERC1-depleted cells (Fig. 1E). 
Incubation with SB203580, an inhibitor of p38 activity, confirmed that HSP27 phosphorylation was dependent 
on p38 activity (Fig. 1F). These effects were intensified after stimulation of p38 activity with hydrogen peroxide 
(H2O2) and strongly inhibited in the presence of p38 inhibitor (Fig. 1F). p38 activation is also associated with its 
translocation to the nucleus. Immunofluorescence experiments showed an increase in p38 phosphorylation and 
its nuclear location in HERC1-depleted cells (Fig. 1G). In conjunction, these results demonstrate the involvement 
of the ubiquitin ligase HERC1 in the regulation of p38 signaling.
HERC1 regulates p38 signaling through the MAPK kinase MKK3. Activation of the p38 MAPK 
is mediated by its phosphorylation by a MAPK kinase (MAPKK or MKK). The MKKs mainly involved in p38 
activation are MKK3 and MKK611. Although, in vitro, MKK4 can also phosphorylate p3812, MKK4 is preferably 
an activator of JNK, and MKK3 and MKK6 are the predominant activators of p3813. MKK3 and MKK6 appear 
to have redundant functions during development, as MKK3 or MKK6 knockout mice are viable whereas double 
knockout mice died during gestation13. We analyzed expression of MKK3 and MKK6 isoforms in human cells. 
Immunoblot analysis using specific antibodies showed expression of MKK3 in U2OS and H1299 cell lines and 
of MKK6 in the HEK-293T cell line (Fig. 2A). Next, we focused on MKK3 expression in HERC1-depleted U2OS 
cells and observed a significant increase in MKK3 protein levels after HERC1 knockdown (Fig. 2B). Interestingly, 
the increase in p38 phosphorylation observed in HERC1-depleted cells was abolished by MKK3 depletion, show-
ing that the increase in p-p38 was caused by MKK3 (Fig. 2C). Experiments in the presence of cycloheximide, a 
translation inhibitor, demonstrated that the increase in MKK3 was not due to an increase in the half-life of MKK3 
(Fig. 2D). Analysis of mRNA levels showed an increase in MKK3 levels in HERC1-depleted cells (Fig. 2E). These 
data suggest that the increase in MKK3 protein levels by HERC1 depletion is caused by an increase in its mRNA 
levels.
The above results led us to analyze whether HERC1 and MKK3 could interact. Immunoprecipitation exper-
iments using different anti-HERC1 antibodies failed to detect interaction between HERC1 and MKK3 (both 
endogenous MKK3 and transfected Flag-MKK3) proteins (Fig. 2F,G).
Because HERC1 is a ubiquitin ligase, we wondered whether HERC1 might be regulating MKK3 ubiquitylation. 
To determine this, we first analyzed MKK3 ubiquitylation in the absence and presence of the proteasome inhibi-
tor MG132. U2OS cells were transfected with constructs expressing Flag-MKK3 or the negative control pcDNA3. 
Forty-eight hours later, lysates from these cells were pulled down using Flag resin. Inputs and pull-down proteins 
were analyzed by PAGE/SDS and immunoblotted with the anti-ubiquitylated proteins antibody (FK2) or with spe-
cific antibodies against the proteins indicated (Fig. 2H). An increase in polyubiquitylated Flag-MKK3 was detected 
with the FK2 antibody in the presence of MG132 (Fig. 2H, lane 8 compared with lane 6), indicating MKK3 regula-
tion by the proteasome. Next, we analyzed the role of HERC1 in MKK3 ubiquitylation. U2OS cells were transfected 
with HERC1 or non-targeting (NT) siRNAs. Twenty-four hours later, cells were also transfected with plasmids 
expressing Flag-MKK3 or pcDNA3 as negative control. Forty-eight hours later, lysates were prepared for pull-down 
experiments. Inputs and pull-downs were analyzed by PAGE/SDS and immunoblotting (Fig. 2I). We observed that 
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the ubiquitylation detected with the FK2 antibody remained unchanged after HERC1 knockdown (Fig. 2I, lane 8 
compared with lane 6). These data suggest that MKK3 ubiquitylation is not regulated by HERC1.
RAF-dependent regulation of MKK3/p38 signaling by HERC1. MAPK signaling pathways are organ-
ized in modular cascades in which activation of upstream kinases leads to sequential activation of a MAPK mod-
ule. Although MAPK pathways are depicted as linear signaling pathways, in some situations crosstalk between 
Figure 1. HERC1 regulates p38 signaling. (A) Lysates from U2OS cells transfected with NT or HERC1 (Q1 or 
Q4) siRNA were analyzed by immunoblotting with antibodies against the indicated proteins. Clathrin heavy 
chain (CHC) levels were used as protein load control. p-p38 levels were quantified and normalized by p38 
levels (n = 4). (B) Lysates from HEK-293T or H1299 cells were analyzed as above. (C) HEK-293T or U2OS cells 
infected with lentivirus shH1 (HERC1 shRNA) or pLKO (the lentivirus plasmid vector as negative control) 
were analyzed by immunoblotting with antibodies against the indicated proteins. (D) MEF cells infected 
with lentivirus were analyzed as above. (E) Lysates from U2OS cells transfected with NT or HERC1 (Q1 or 
Q4) siRNA were analyzed as in (A). p-HSP27 levels were quantified and normalized by HSP27 levels (n = 4). 
(F) U2OS cells were transfected with NT or HERC1 siRNA. Seventy-two hours post-transfection, they were 
treated with the p38 kinase activity inhibitor, SB203580 (10 μM for 1 hour), and subsequently with hydrogen 
peroxide (H2O2) for 30 minutes. The cell lysates were analyzed as in (A). (G) U2OS cells transfected with NT or 
HERC1 (Q1) siRNA were stained for p-p38 (green), F-actin (red), and nuclei (blue) and analyzed by confocal 
microscopy. Data are expressed as mean ± S.E.M. Statistical analysis was carried out as described in “Materials 
and Methods”. Significant differences are relative to NT siRNA. **p < 0.01; ***p < 0.001.
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Figure 2. HERC1 regulates p38 signaling trough MKK3. (A) Two independent lysates for each human cell 
line (U2OS, H1299, and HEK-293T) were analyzed by immunoblotting to evaluate MKK3 and MKK6 protein 
expression. CHC levels were used as protein load control. (B) Lysates from U2OS cells transfected with NT or 
HERC1 (Q1) siRNA were analyzed by immunoblotting with antibodies against the indicated proteins. MKK3 
levels were quantified and normalized by CHC levels (n = 4). (C) Lysates from U2OS cells transfected with 
NT, HERC1 (Q1), or MKK3 siRNA were analyzed by immunoblotting with antibodies against the indicated 
proteins. (D) U2OS cells were transfected with NT or HERC1 siRNA. Seventy-two hours post-transfection, 
cells were treated with cycloheximide for 0, 4, 8, 12, and 16 h. Time-course of MKK3 expression was analyzed 
by immunoblotting. CHC levels were used as protein load control and p21 levels as a validation control of the 
experiment. (E) U2OS cells transfected with NT or HERC1 (Q1) siRNA were analyzed by quantitative real-time 
PCR (RT-qPCR). MKK3 mRNA expression levels were quantified and the housekeeping gene TBP was used 
to normalize them (n = 8). (F) Supernatants (input) of lysates from HEK-293T cells were immunoprecipitated 
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MAPK signaling pathways has been reported14. The observation that HERC1 regulates the RAF/MEK/ERK mod-
ule8 led us to ask whether this module could be involved in p38 activation. To test this, we decided to use specific 
inhibitors for some of these kinases. We observed that in the presence of U0126, a highly selective inhibitor of 
MEK activity, MKK3 (p-p38) and p38 (p-HSP27) activation by HERC1 knockdown was not inhibited, whereas 
ERK phosphorylation (p-ERK) was impaired (Fig. 3A, lanes 5–6 compared with 1–2). In the presence of the 
inhibitor of p38 activity, ERK activation (p-ERK) by HERC1 knockdown was not inhibited, whereas p38 activity 
(p-HSP27) was impaired (Fig. 3A, lanes 3–4 compared with 1–2). Notably, in the presence of the inhibitor of 
RAF activity (LY3091020), MKK3 and p38 activation was strongly inhibited (Fig. 3A, lanes 9–10 compared with 
1–2). As expected, under these conditions ERK activation was inhibited (Fig. 3A, lanes 9–10 compared with 1–2). 
We confirmed these results using another inhibitor of RAF activity (Sorafenib), observing decreased p38 activa-
tion in the presence of Sorafenib (Fig. 3A, lanes 11–12 compared with 1–2). Interestingly, this inhibition of p38 
activation was higher with LY3091020 than with Sorafenib (Fig. 3A), probably due to the different specificities 
of these inhibitors: Sorafenib is an inhibitor of B-RAF and C-RAF isoforms, while LY3091020 inhibits all RAF 
isoforms15,16.
The above experiments show that activation of MKK3/p38 signaling by HERC1 knockdown was dependent 
on RAF activity. Notably, these data indicate a crosstalk between RAF and p38 signaling pathways. To confirm 
these results using another experimental approach, we decided to perform knockdown experiments of the three 
isoforms of RAF (A-RAF, B-RAF, and C-RAF). The MKK3 and p38 activation observed in HERC1-depleted cells 
was inhibited by knockdown of RAF isoforms (Fig. 3B).
HERC1 regulates RAF-dependent MKK3 expression. The increase in MKK3 protein levels in 
HERC1-depleted cells led us to analyze whether this increase was mediated by RAF proteins. We observed that 
knockdown of RAF isoforms abolished the increase in MKK3 in HERC1-depleted cells (Fig. 3C). In agree-
ment with this, p38 phosphorylation was also suppressed (Fig. 3C). An analysis of mRNA levels showed that 
the increase in MKK3 expression in HERC1-depleted cells was abolished by RAF knockdown (Fig. 3D). In 
conjunction, these results suggest that MKK3 expression is regulated by HERC1 via a RAF protein-dependent 
mechanism.
HERC1 regulates cell migration. MAPKs play crucial roles in cell migration, a process that is central to 
embryonic development, plays a major role in cancer invasion and metastasis, and is known to involve ubiqui-
tylation4,6,17. Cell migration can be analyzed through a wound healing assay in which a cell-free area is created 
in a confluent monolayer by physical exclusion or by removing the cells from the area. Exposure to the cell-free 
area induces cells to migrate into the gap. In our experiments, the monolayer was scratched with a pipette tip and 
migration into the gap was imaged over 12 hours using a transmitted light microscope. Images were analyzed and 
the cell-free area represented (Fig. 4A, Control). In this model, we studied whether cell migration was dependent 
on p38 activity. In the presence of an inhibitor of p38 activity, a significant delay in wound healing was observed 
at 6 and 12 hours (Fig. 4A, SB203580).
Because cell migration is regulated by p38 activity and HERC1 regulates p38 activity (Fig. 1), we won-
dered whether HERC1 might be regulating cell migration. To test this, we performed wound healing assays 
in HERC1-depleted U2OS cells. We observed a significant increase in wound healing at 6 and 12 hours in 
HERC1-depleted cells (Fig. 4B). To determine whether this HERC1 regulation of cell migration was mediated by 
p38 activity, we performed wound healing assays in the presence of an inhibitor of p38 activity. We found that the 
increase in wound healing observed at 6 and 12 hours in HERC1-depleted cells was inhibited in the presence of 
the p38 inhibitor (Fig. 5, compare Q1 with Q1 + SB conditions).
RAF-dependent regulation of cell migration by HERC1. Since HERC1 regulation of p38 activity was 
dependent on RAF activity (Fig. 3), we decided to study whether HERC1 regulation of cell migration was also 
dependent on RAF activity. Thus, we performed wound healing assays in the presence of an inhibitor of pan-RAF 
activity. We observed that cell migration was dependent on RAF activity (Fig. 5, compare NT with NT + LY con-
ditions) and that the increase in wound healing at 6 and 12 hours in HERC1-depleted cells was strongly inhibited 
in the presence of the RAF inhibitor (Fig. 5, compare Q1 with Q1 + LY conditions).
We analyzed whether the above results obtained in human osteosarcoma cells were maintained in other spe-
cies. To this end, we performed wound healing assays in mouse embryonic fibroblasts (MEFs). First, we found 
that cell migration in these mouse cells was regulated by p38 and RAF proteins (Fig. 6, compare pLKO control 
(IP) using anti-HERC1 antibodies (Bvg6 and 411) and analyzed by immunoblotting with antibodies against 
the indicated proteins. Pre-immune serum (PI) was used as a negative control. (G) Supernatants (input) of 
lysates from HEK-293T cells transfected with Flag-MKK3 were immunoprecipitated (IP) using anti-HERC1 
antibodies (363 and 410) and analyzed as above. Pre-immune serum (PI) was used as a negative control. 
(H) U2OS cells transfected with pcDNA3 or Flag-MKK3 were incubated in the presence of the proteasome 
inhibitor MG132 (10 μM) for 6 hours. Control cells were incubated with dimethyl sulfoxide (DMSO). Flag 
pull-down was performed as indicated in “Materials and Methods”. Proteins retained in the resin were analyzed 
by immunoblotting with the indicated antibodies. (I) U2OS cells were transfected with NT or HERC1 siRNA. 
Twenty-four hours later, cells were transfected with pcDNA3 or Flag-MKK3 plasmids. Forty-eight hours later, 
Flag pull-down was performed as indicated in “Materials and Methods”. Inputs and pull-downs were analyzed 
as in (H). Statistical analysis was carried out as described in “Materials and Methods”. Significant differences are 
relative to NT siRNA. **p < 0.01; ***p < 0.001.
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Figure 3. RAF-dependent regulation of MKK3/p38 signaling by HERC1. (A) U2OS cells were transfected with 
NT or HERC1 (Q1) siRNA. Seventy-two hours post-transfection, cells were treated with 10 μM of SB203580, 
U0126, LY3009120, or Sorafenib for 1 hour. Control cells were incubated with dimethyl sulfoxide (DMSO). 
Lysates from U2OS cells were analyzed by immunoblotting. p-p38 levels were quantified and normalized by 
p38 levels (n = 4). (B) Lysates from U2OS cells transfected with the indicated siRNA (NT: non-targeting; Q1: 
HERC1; A: A-RAF; B: B-RAF; and C: C-RAF) were analyzed by immunoblotting with antibodies against the 
indicated proteins. (C) Lysates from U2OS cells transfected with the indicated siRNA (NT: non-targeting; 
Q1: HERC1; A: A-RAF; B: B-RAF; and C: C-RAF) were analyzed by immunoblotting with antibodies against 
the indicated proteins. MKK3 levels were quantified and normalized by CHC levels (n = 4). (D) U2OS cells 
transfected with the indicated siRNA (NT: non-targeting; Q1: HERC1; A: A-RAF; B: B-RAF; and C: C-RAF) 
were analyzed by RT-qPCR. MKK3 mRNA expression levels were quantified and levels of the housekeeping 
gene TBP were used to normalize them (n = 8). Data are expressed as mean ± S.E.M. Statistical analysis was 
carried out as described in “Materials and Methods”. * or #p < 0.05; ** or ##p < 0.01; *** or ###p < 0.001.
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with pLKO + SB conditions, and pLKO control with pLKO + LY conditions, respectively). Next, MEFs were 
infected with lentivirus expressing shRNA against HERC1 (shH1) and we found an increase in wound heal-
ing in HERC1-depleted cells (Fig. 6, compare pLKO with shH1 conditions). Under these conditions, regulation 
of cell migration by HERC1 knockdown was inhibited in the presence of the p38 inhibitor (Fig. 6, compare 
shH1 with shH1 + SB conditions) and the RAF inhibitor (Fig. 6, compare shH1 with shH1 + LY conditions). An 
Figure 4. HERC1 regulates cell migration. (A) In vitro wound healing assay of U2OS cells (magnification x100). 
Cells were seeded onto 6-well cell culture plates and cultured to confluency. Cells were non-treated (control) 
or treated with 10 μM of SB203580 for 1 hour. Subsequently, a cell-free area was created (linear wound) using a 
sterilized 10 μL tip. Cell migration into the wound area was monitored. Representative time-lapse microscopy 
snapshots at specific time points (0, 3, 6, 12 h) were used to compare cell migration between groups (n = 4). (B) 
U2OS cells were transfected with NT or HERC1 (Q1) siRNA. Seventy-two hours post-transfection, an in vitro 
wound healing assay was performed as indicated above. Data are expressed as mean ± S.E.M. Statistical analysis 
was carried out as described in “Materials and Methods”. *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 5. RAF activity-dependent regulation of cell migration by HERC1. U2OS cells were transfected with 
NT or HERC1 (Q1) siRNA for seventy-two hours. Cells cultured to confluency were non-treated or treated with 
10 μM of SB203580 or LY3009120 for 1 hour. Next, an in vitro wound healing assay was performed as indicated 
in Fig. 4. Representative time-lapse microscopy snapshots at specific time points (0, 3, 6, 12 h) were used to 
compare cell migration between groups (n = 4). Percentages of cell-free area are expressed as mean ± S.E.M. 
Statistical analysis was carried out as described in “Materials and Methods”. **p < 0.01 represents differences 
relative to NT siRNA. +++p < 0.001 represents differences between NT siRNA non-treated and treated with 
SB203580 or LY3009120 at the same time point. ###p < 0.001 represents differences between Q1 siRNA non-
treated or treated with SB203580 or LY3009120, at the same time point.
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Figure 6. Regulation of cell migration by HERC1 in mouse embryonic fibroblasts (MEFs). MEFs were 
infected with lentivirus shH1 (HERC1 shRNA) or pLKO (the lentivirus plasmid vector as negative control). 
After selection of infected cells, an in vitro wound healing assay was performed as described in Fig. 4 (n = 4). 
Percentages of cell-free area are expressed as mean ± S.E.M. Statistical analysis was carried out as described 
in “Materials and Methods”. **p < 0.01 represents differences relative to pLKO. +++p < 0.001 represents 
differences between pLKO non-treated and treated with SB203580 or LY3009120, at the same time point. 
###p < 0.001 represents differences between shH1, non-treated and treated with SB203580 or LY3009120, at the 
same time point.
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immunoblot analysis demonstrated that p38 was activated in HERC1-depleted MEFs and that the presence of the 
RAF inhibitor was sufficient to abrogate this activation (Fig. 6).
Together, the above results demonstrate the regulation by HERC1 of cell migration in a RAF-dependent man-
ner. To confirm these data, we tested a rescue experiment using the HERC1 cDNA but we could not observe a 
significant expression of this cDNA probably due to its large size (15 kbp for coding a protein of 532 kDa). The use 
of plasmids expressing different regions (1–1334 and 1–2958 amino acid residues) of HERC1, including C-RAF 
binding site, was not enough to modify cell migration regulated by HERC1 knockdown. As an alternative, we 
performed knockdown experiments of the three isoforms of RAF. The increase in wound healing observed at 6 
and 12 hours in HERC1-depleted U2OS cells was rescued by knockdown of RAF isoforms (Fig. 7).
Discussion
HERC1 has previously been characterized as a ubiquitin E3 ligase regulating the ERK signaling pathway in cell 
proliferation8. Here, we provide the first evidence that HERC1 also acts as a regulator of the p38 signaling path-
way, and that this regulation is mediated by the MAPK kinase MKK3. Notably, we demonstrate an unexpected 
crosstalk between RAF and MKK3/p38 pathways, in which RAF proteins act upstream of MKK3 protein and 
HERC1 regulates RAF activity. The importance of this crosstalk and its regulation by HERC1 is highlighted 
during cell migration. These functions are evolutionarily conserved as HERC1 and RAF work similarly in mouse 
cells. In summary, our results reveal an unknown role of HERC1 in the regulation of cell migration, acting as a 
regulator of the crosstalk between RAF/MKK3/p38 signaling pathways.
The E3 ligase HERC1 polyubiquitylates C-RAF, labeling it for proteasomal degradation8 and thus regulating 
C-RAF proteostasis. C-RAF is one of the three RAF family isoforms (A, B, and C) in humans. This family acts 
on the ERK signaling pathway as the first kinase (MAPKKK) of the cascade of this module (RAF/MEK/ERK). 
Stimuli that activate the RAS GTPase activate homodimers and/or heterodimers of the RAF proteins that phos-
phorylate and activate MEK (MEK1/2), which in turn phosphorylates and activates ERK (ERK1/2). Thus, ERK 
Figure 7. RAF-dependent regulation of cell migration by HERC1. U2OS cells were transfected with the 
indicated siRNA (NT: non-targeting; Q1: HERC1; A: A-RAF; B: B-RAF; and C: C-RAF). Seventy-two hours 
post-transfection, an in vitro wound healing assay was performed as indicated above. Percentages of cell-free 
area are expressed as mean ± S.E.M. Statistical analysis was carried out as described in “Materials and Methods”. 
*p < 0.05 represents differences relative to NT siRNA. +++p < 0.001 represents differences between NT siRNA 
and NT + RAF (A + B + C) siRNAs at the same time point. ###p < 0.001 represents differences between Q1 
siRNA and Q1 + RAF (A + B + C) siRNAs, at the same time point.
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can transmit the stimulus signal phosphorylating multiple substrates that act on numerous cellular processes. 
HERC1 plays a role in this signaling pathway by regulating C-RAF protein levels (Fig. 8). Another MAPK signa-
ling pathway is the p38 signaling pathway. Thus, a MAPKKK activated by stress stimuli phosphorylates and acti-
vates MKK3/MKK6, and these phosphorylate and activate p38. Like ERK, p38 phosphorylates multiple substrates 
that act on different cellular processes. Although MAPK pathways are depicted as linear signaling pathways, 
crosstalk between MAPK signaling pathways has been observed in some situations18. Here, we demonstrate that 
HERC1 regulates the p38 signaling pathway. Thus, HERC1 depletion rendered it possible to observe p38 activa-
tion in an MKK3-dependent manner (MKK6 was not detected in U2OS cells), and we found that under these 
conditions, MKK3 levels increased, which might suggest that MKK3 was the substrate for HERC1 ubiquitylation; 
however, association and ubiquitylation experiments showed that this was not the case. An analysis of MKK3 
mRNA levels demonstrated a correlation with its protein levels, suggesting the involvement of a pre-translational 
regulation mechanism. The use of specific inhibitors or of siRNA against RAF isoforms showed that this acti-
vation of MKK3 and p38 was dependent on RAF proteins. In conjunction, this study demonstrates a crosstalk 
between RAF and MKK3 regulated by HERC1 (Fig. 8). Although we have not studied, we cannot discard a pos-
sible regulation of p38 signaling by other E3 ligases regulating stability and activity of C-RAF like X-linked and 
cellular IAPs19 or HUWE120.
It has previously been shown that the specific antibody for the phosphorylated form of p38 used here recog-
nizes two bands in U2OS cells, where the lower band corresponds to the p38α isoform and the upper band to 
p38γ, with the lower band being the most abundant21. Although we did not analyze the specific role of p38 iso-
forms, the use of a specific inhibitor for the p38α/β isoforms and the detection mainly of the lower band (Fig. 1) 
both suggest the involvement of the p38α isoform.
Activation of p38 is induced by most stress stimuli, including UV light, oxidative stress, and heat or osmotic 
shock, but also by exposure to cytokines, chemokines, hormones, and growth factors. One of the first reported 
p38 substrates was MK2. Active MK2 phosphorylates HSP27, resulting in actin filament remodeling and stim-
ulation of cell migration22. Here, we show that HERC1 elimination increases HSP27 phosphorylation due to 
activation of p38, which results in an increase in cell migration. In addition, experiments in the presence of the 
inhibitor LY3009120 demonstrated that cell migration was dependent on RAF proteins that acted upstream of 
MKK3 and p38. Interestingly, the observed increase in cell migration due to HERC1 knockdown was completely 
rescued by inhibiting RAF activity or by knockdown of RAF isoforms, which implies that the observed effect of 
HERC1 on migration is mediated by RAF. Since HERC1 specifically regulates C-RAF isoform levels, it is highly 
likely that HERC1 regulation of migration is dependent on C-RAF. These observations agree with previous data 
showing that C-RAF regulates cell migration9. These authors correlated the defect in migration of C-RAF knock-
out (KO) cells with hyperactivity and incorrect localization of the Rho-associated kinase α (ROCKα) at the 
plasma membrane. Reintroduction of either wild-type or kinase-dead C-RAF in KO fibroblasts rescued the defect 
in migration. These latter observations suggest a kinase-independent function of C-RAF during migration9. Our 
experiments with LY3009120, a pan-RAF inhibitor of the three isoforms15, might indicate a kinase-dependent 
function. An explanation for these apparently contradictory conclusions might be that RAF proteins could act 
as heterodimers. Thus, reintroduction of kinase-dead C-RAF in KO fibroblasts could rescue the defect in migra-
tion, forming heterodimers with active A-ARF or B-RAF isoforms. Since RAF inhibitors such as LY3009120 
or Sorafenib induce RAF dimerization15, another possibility could be that the C-RAF isoform is sequestered 
in inactive dimers (heterodimers or homodimers), preventing its interaction with ROCKα and inhibiting cell 
Figure 8. Working model for the regulation of cell migration by the ubiquitin ligase HERC1. RAS activation 
by external stimuli provides the anchor for homo- or heterodimerization of RAF proteins (A-RAF, B-RAF, and 
C-RAF). The activated dimer then phosphorylates and activates the downstream kinase MEK (MEK1/2), which 
in turn phosphorylates and activates ERK (ERK1/2). HERC1 plays a role in this signaling pathway by regulating 
C-RAF protein levels. Stress and other stimuli activate the MKKK/MKK3/p38 cascade. HERC1 knockdown 
increases C-RAF and MKK3 levels, resulting in ERK and p38 activation, which increases cell migration.
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migration. In support of the involvement of Rho signaling in p38 activation during cell migration, it has been 
suggested that a Rho/ROCK/FAK/p38 signaling pathway mediates the stimulation of intestinal epithelial migra-
tion produced by repetitive deformation23, and that a Rho/ROCK/MKK3/p38 signaling pathway regulates 
sphingosine-1-phosphate-induced smooth muscle cell migration24. Other MAPK signaling pathways such as JNK 
or ERK also play crucial roles in cell migration. For example, ERK regulates cell movement by phosphorylating 
myosin light chain kinase, calpain, and focal-adhesion kinase4,5. Through C-RAF, HERC1 also regulates the ERK 
signaling pathway8. Thus, HERC1 regulates cell migration by modulating both ERK and p38 signaling pathways.
This study reflects the complex regulation of biological processes where ubiquitylation and phosphorylation 
mechanisms participate in an integrated manner to transmit signaling. Although more research is required to 
fully understand the functions of HERC1, its role in regulating cell migration (this study) and cell proliferation8 
sheds light on why HERC1 mutations have been associated with serious pathologies, including tumorigenesis 
and neurological disorders7. In this context, FDA-approved RAF inhibitors are potential candidates for use as 
therapeutic drugs in these pathologies.
Material and Methods
Reagents. We used the following reagents: anti-p-p38 (Cell Signaling); anti-p-HSP27 (Enzo Life Sciences); 
anti-p38, anti-HSP27, anti-α-tubulin and anti-β-actin (Santa Cruz Biotechnology); anti-MKK3 and anti-MKK6 
(Proteintech Europe); anti-p44/42 MAPK (ERK1/2) (Cell Signaling); anti-p-ERK1/2 (Sigma-Aldrich); anti-
HERC1 (Bvg6, 411, 363, 410)25; anti-C-RAF and anti-clathrin heavy chain (BD Biosciences); anti-A-RAF(A-5) 
and anti-B-RAF (F-7) (Santa Cruz Biotechnology); ubiquitylated proteins (clone FK2) (Biomol); anti-c-myc 
(clone 9E10) (Roche); anti-Flag M2 (Sigma-Aldrich); DAPI (Sigma-Aldrich); phalloidin-Alexa 647 (BioProbes); 
conjugated secondary antibodies to Alexa-Fluor 488 and horseradish peroxidase-conjugated secondary anti-
bodies (Invitrogen); Immobilon-P PVDF transfer membrane (Millipore Corporation); SB203580 (Selleckchem); 
U0126 (Calbiochem); LY3009120 (Selleckchem); Sorafenib (Santa Cruz Biotech.); MG132 (Merck Millipore); 
anti-Flag M2 affinity gel (Sigma-Aldrich); Luminescent β-galactosidase detection Kit II (Clontech Laboratories); 
and Luciferase assay system (Promega).
Plasmids and siRNAs. pRc/RSV-Flag-MKK3 and pcDNA3 constructs were purchased from 
Addgene and Invitrogen, respectively. shRNA and siRNA were previously described8. Briefly, human 
HERC1 shRNA (TRCN0000235499) and vector pLKO.1-Puro were from Sigma-Aldrich. siR-
NAs were purchased from GenePharma: non-targeting (NT, UAGCGACUAAACACAUCAA), 
HERC1 (Q1, CGGCAUGGAUGAACAAAUU and Q4, GGGCAGAACUUCGUUUAGA), A-RAF 
(AACAACATCT TCCTACATGAG),  B-RAF (AAAGAAT TGGATCTGGATCAT) and C-RAF 
(UAGUUCAGCAGUUUGGCUATT).
Transfections and cell culture. U2OS, HEK-293T and MEFs cells were cultured at 37 °C in DMEM 
(Dulbecco’s Modified Eagle’s Medium, Gibco) with 10% fetal bovine serum. Transfection of cells was performed 
as previously described8 using Lipofectamine LTX (Invitrogen) for plasmids and calcium phosphate for siRNAs. 
Specific inhibitors were used at a final concentration of 10 μM (U0126, SB203580, Sorafenib and LY3009120 for 
1 hour, and MG132 for 6 hours). Preparation and infection of lentiviral particles were carried out according to the 
manufacturer’s instructions (Sigma-Aldrich).
Lysates and immunoblotting. Lysates were prepared with NP40 buffer as previously described8 and cen-
trifuged at 13,000 x g at 4 °C for 10 min. Supernatants were analyzed by electrophoresis and immunoblotting 
using the Tris-acetate PAGE system26. Band intensities were analyzed using a gel documentation system (LAS-
3000 Fujifilm). Protein levels were normalized and expressed as a percentage of controls. The levels of phospho-
rylated proteins (p-p38, p-ERK1/2, and p-HSP27) were normalized by their total amount. Raw data are shown in 
supplementary information.
Immunoprecipitation and pull-downs. For Flag pull-downs, the above supernatants were incubated 
at 4 °C with 5 μL of anti-Flag M2 affinity gel for 2 hours. Next, they were centrifugated and pull-downs were 
washed with NP40 buffer (five times) and analyzed by electrophoresis and immunoblotting as indicated above. 
For immunoprecipitation (IP), supernatants (input) were incubated at 4 °C with anti-HERC1 polyclonal antibod-
ies (Bvg6, 411, 363, 410) or with pre-immune serum (PI) for 2 hours. Next, protein A-Sepharose was added for 
1 hour. Beads were pelleted by centrifugation at 2,500 g, washed with NP40 buffer (four times), and analyzed as 
indicated above.
Confocal microscopy. U2OS cells grown on glass coverslips were fixed at room temperature for 20 min 
with 4% paraformaldehyde. Cells were permeabilized for 20 minutes with 0.05% saponin in PBS containing 
0.5% bovine serum albumin. The primary antibody, anti-p-p38 (1:200), was incubated at 37 °C for 1 hour. After 
washing, Alexa-Fluor 488 secondary antibody (1:500) was incubated at 37 °C for 45 minutes. Incubation with 
phalloidin-Alexa 647 (100 ng/mL) for 20 minutes at room temperature was used to detect F-actin. Nuclei were 
stained with DAPI (1 μg/mL). Images were acquired using a confocal laser scanning microscope (LSM 880 spec-
tral, Carl Zeiss Microscopy GmbH, Jena, Germany).
Reverse transcriptase quantitative PCR analysis (RT-qPCR). Total RNA was isolated from U2OS cells 
using Trisure reagent following the manufacturer’s protocol (Bioline). Total RNA (2 μg) was reverse-transcribed 
using the high capacity cDNA Reverse Transcription kit (Applied Biosystems). PCR amplification reactions 
were performed with the ABI Prism 7900 HT Fast Real-Time PCR System. Applied Biosystems’ TaqMan Gene 
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Expression Assays were used to quantify gene expression of MKK3 (Hs00177127_m1) and the housekeeping 
gene TBP (HS99999910_m1), which was used to normalize. Data from PCR were acquired and analyzed using 
Sequence Detector software (Applied Biosystems, SDS version 2.3).
Wound healing assay. Following 48 h of siRNA transfection, U2OS cells (3 × 105/well) were seeded 
in 6-well plates. When the cells reached 100% confluency, the cells were non-treated or treated with 10 μM of 
SB203580 or LY3009120 for 1 hour. Subsequently, a cell-free area was created (linear wound). The scratch closure 
was monitored and documented after 0, 3, 6, and 12 hours, using a Leica DM IRB Inverted Research Microscopy 
(Leica Microsystems Wetzlar GmbH). Similar results were obtained when cells at 100% confluency were pre-
treated with 10 μg/mL mitomycin C for 2 h. Wound area was determined using ImageJ software.
Statistical analysis. Results were analyzed using GraphPad Prism 5 software. Data are expressed as 
mean ± S.E.M. Differences between groups were analyzed using the Student’s t-test or one-way analysis of vari-
ance (ANOVA) with Bonferroni’s multiple comparison test. Statistical significance was set at p < 0.05.
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